Relationship of Neuropsychiatric Symptoms with Falls in Alzheimer's Disease : Does Exercise Modify the Risk? by Roitto, Hanna-Maria et al.
BRIEF REPORT
Relationship of Neuropsychiatric Symptoms with Falls in
Alzheimer’s Disease – Does Exercise Modify the Risk?
Hanna-Maria Roitto, MD,*† Hannu Kautiainen, PhD, biostatistician,*‡ Hannareeta Öhman, MD,*†
Niina Savikko, RN, PhD,*§ Timo E. Strandberg, MD, PhD,¶k** Minna Raivio, MD, PhD,*
Marja-Liisa Laakkonen, MD, PhD,*† and Kaisu H. Pitkälä, MD, PhD*‡
OBJECTIVES: To explore how neuropsychiatric symptoms
(NPS) are associated with number of falls and how exercise
modifies the risk of falling in community-dwelling people
with Alzheimer’s disease (AD) and NPS.
DESIGN: Secondary analysis of a randomized controlled
trial.
SETTING: Community.
PARTICIPANTS: Community-dwelling individuals with
AD (N=210) who completed the Neuropsychiatric Inven-
tory (NPI) (N = 179).
INTERVENTION: Participants were randomized into
3 groups: group-based exercise (4-hour sessions with
approximately 1 hour of training) and tailored home-based
exercise (1 hour of training) twice a week for 1 year and a
control group receiving usual community care. In this sec-
ondary analysis, we merged the home-based and group-
based exercise groups and compared this group with the
control group.
MEASUREMENTS: NPS were measured using the NPI at
baseline, and spousal caregivers recorded falls in daily fall
diaries during 1 year of follow-up.
RESULTS: The number of falls increased linearly with NPI
score in the control group. Fall rates were 1.48 (95% confi-
dence interval (CI)=1.26–1.73) per person-year in the interven-
tion group and 2.87 (95% CI=2.43–3.35) in the control
group. Adjusted for age, sex, Mini-Mental State Examination
(MMSE) score, and Short Physical Performance Battery
(SPPB) score, incidence rate ratio (IRR) was 0.48 (95%
Cl=0.39–0.60, p < .001). Main effects for fall rate were signifi-
cant for group (p < .001) and NPI total (p < .02); the interac-
tion effect was also significant (p = .009) (adjusted for sex, age,
MMSE score, SPPB score, and psychotropicmedication use).
CONCLUSION: Exercise may decrease the risk of falling in
community-dwelling individuals with AD and NPS. Future
exercise trials should confirm this finding in participants
with significant NPS.
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Alzheimer’s disease (AD) is characterized by cognitiveand functional decline1 and is associated with neuro-
psychiatric symptoms (NPS) and falls.2,3 Up to 90% of indi-
viduals with AD will experience at least 1 significant NPS
during the course of the disease.4 NPS seem to be highly
persistent, and clinically significant symptoms may indicate
poor prognosis, caregiver burden, and high care costs.4
People with dementia have a significantly higher risk of
falling than those without.2 The risk is twice as high
community-dwelling people with dementia than in those
without dementia.5 Approximately 60% of older persons
with dementia or cognitive impairment fall annually.6,7
Studies have suggested that NPS predict falls.8–10
Exercise reduces the number of falls in older adults
with dementia.11 The Finnish Alzheimer Disease Exercise
(FINALEX) trial showed that a long-term intensive exercise
intervention decreased the number of falls in community-
dwelling people with AD.12 Few studies have explored the
association between NPS and falls. Even less is known
about how exercise modifies the risk of falls in people with
dementia and NPS. The aim of this study was to examine
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the relationship between NPS and falls and whether a long-
term exercise intervention would reduce the risk of falling
in community-dwelling people with AD and NPS.
METHODS
This report is a secondary analysis of a randomized inter-
vention trial investigating the effects of an exercise program
on older adults with AD (FINALEX). The study included
individuals in all stages of AD with NPS. The design, base-
line findings, feasibility, and endpoints of the trial have been
presented previously.12,13 The original FINALEX study
examined and compared home-based exercise and group-
based exercise groups, with the control group receiving reg-
ular community care. Physiotherapists supervised both
intervention arms, which included similar components such
as balance, endurance, strength, and multitask training. The
1-hour supervised training took place twice a week over
1 year in both groups. For this secondary analysis, we
merged the 2 exercise groups into a single intervention
group that we compared with the control group to increase
the statistical power of the study.
Participants
The Social Insurance Institution of Finland recruited
community-dwelling people with AD living in the cities of
Helsinki, Vantaa, and Espoo to this study based on its drug
reimbursement register. For an individual to be included in
this register, a neurologist or a geriatrician must have diag-
nosed him or her with AD based on the National Institute of
Neurological and Communicative Disorders and Stroke and
the Alzheimer’s Disease and Related Disorders Association
Alzheimer’s criteria. A letter offering the possibility of partici-
pating in the exercise trial was mailed to all 1,264 of these
individuals. Those who expressed an interest in participating
(n = 497) received a postal questionnaire asking for infor-
mation on inclusion criteria: established AD, aged 65 and
older, living with a spouse at home, no diagnosed terminal
disease, and walking independently with or without a
mobility aid. Participants were also required to have at
least 1 of the following signs of frailty: 1 or more falls in
the past year, a decrease walking speed, and unintentional
weight loss. After receiving the completed questionnaire,
the study nurse conducted a telephone interview with the
spousal caregiver to ensure that all inclusion criteria were
met. Two hundred ten participants met the inclusion cri-
teria and were enrolled in the study. In this substudy, we
included all participants (N = 179) whose spousal care-
giver completed the Neuropsychiatric Inventory (NPI)14
information in the assessments.
Measures
A trained nurse and a physiotherapist assessed all partici-
pants and interviewed their spousal caregivers. Data on
demographic factors were collected at baseline (age, sex,
education, medication, comorbidities, and severity of AD
based on the Mini-Mental State Examination (MMSE)15
and Clinical Dementia Rating (CDR).16 Functional status
was evaluated using the Functional Independence Mea-
sure (FIM).17 Mobility was assessed using the Short
Physical Performance Battery (SPPB).18 Nutritional state
was assessed and graded using the Mini Nutritional
Assessment (MNA).19 Spouses gave information on falls
in the individuals with AD during the year preceding the
trial. Information on participant diagnoses and medica-
tions was retrieved from their medical records. The
Charlson Comorbidity Index was calculated, as described
elsewhere.20 Medications were classified using the Ana-
tomical Therapeutic Chemical (ATC) classification sys-
tem (WHO, 2015). We included acetylcholinesterase
inhibitors (N06DA) and memantine (N06DX01) as AD
medications. Psychotropic medications included antipsy-
chotics (N05A), antidepressants (N06A), anxiolytics
(N05B), and hypnotics and sedatives (N05C).
To evaluate NPS, spouses were interviewed using
the NPI,14 which asks about 12 common dementia NPS
(delusions, hallucinations, agitation, dysphoria, anxiety,
apathy, irritability, euphoria, disinhibition, aberrant
motor behavior, sleep disturbances, eating abnormali-
ties). For each symptom, severity is multiplied by fre-
quency, and the sum score provides the total NPI score
(range 0–144). Subsyndromes of hyperactivity, mood
and apathy, and psychosis were calculated separately, as
described previously.21 Depression was evaluated using
the Cornell Depression Scale.22 Participants’ spouses
recorded falls during the 1 year of follow-up in daily fall
diaries.
Intervention
A detailed description of the intervention has been pro-
vided previously.23 Before the intervention, a geriatrician
assessed each participant’s health status to ensure the
participant’s safety. The intervention groups exercised
under the supervision of a physiotherapist for 1 hour
twice a week over 1 year in their own home or at the
gym. The exercise sessions comprised strength, balance,
endurance, and multitask training, including training on
a restorator bicycle, Nordic walking, stair climbing, pick-
ing up items from the floor, and talking while walking.
The control group received normal community care
(rehabilitation in the public healthcare system, including
physiotherapy if needed).
Statistics
Sociodemographic, clinical, and drug treatment data of
the groups were compared using the t-test for normally dis-
tributed continuous variables, bootstrapped type t-test for
non-normally distributed continuous variables, Wilcoxon
rank-sum test for differences in NPI, chi-square test for
categorical variables, and Fisher–Freeman–Halton test for
differences in CDR and MNA. The number and incidence
rate of falls were calculated assuming a Poisson distribution.
Adjusted incidence rate and incidence rate ratio (IRR) were
calculated using a Poisson regression model that included
sex, age, MMSE score, and SPPB total score as covariates.
The Poisson regression was tested using goodness of fit of
the model, and the assumption of overdispersion in the Pois-
son model was tested using the Lagrange multiplier test. The
normality of variables was evaluated using the Shapiro–Wilk
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W test. All analyses were performed using Stata version 15.0
(Stata Corp., College Station, TX).
Statement of Ethics
The Helsinki University Central Hospital ethics committee
approved the study protocol. Informed consent was
obtained from each participant or, in case of significant
cognitive decline (CDR 2 or 3), from the closest proxy.
RESULTS
There were no significant differences between the study
groups in baseline characteristics (Table 1). Mean partici-
pant age was 78, and two-thirds were men. Two-thirds had
advanced dementia (CDR 2–3), and mean MMSE score
was 18. Most participants were taking AD medication, and
one-third were taking a psychotropic medication. Partici-
pants had a mean of 2.5 comorbidities, and mean FIM
score was 89 (range 18–126). Only one-quarter were well
nourished according to MNA. Thirty-nine percent had
fallen during the year preceding the intervention. The par-
ticipants had few and mild NPS. Mean participant NPI
score was 14.0.
Interaction Effects of Exercise Intervention and NPI
Score on Fall Rate
Falls had a clear relationship with NPI score in the control
group. The incidence of falls increased linearly with NPI
score in the control group, whereas the exercise intervention
group showed no such relationship. Fall rate was 1.48
(95% CI=1.26–1.73) per person-years in the intervention
group and 2.87 (95% CI=2.43–3.35) in the control group.
Adjusted for age, sex, MMSE score, and SPPB score, IRR
was 0.48, (95% CI=0.39–0.60), (p < .001) for the interven-
tion group compared with the control group. Figure 1
shows the interaction in fall rate between groups and NPI
baseline total score. The main effects for fall rate were sig-
nificant for group (p < .001) and NPI total (p < .02); the
Table 1. Baseline Characteristics of Exercise Intervention and Control Groups
Intervention, n = 120 Control, n = 59 P-Value1
Age, meanSD 77.65.3 78.15.3 .49
Men, n (%) 76 (63.3) 34 (57.6) .46
Education <8 years, n (%) 43 (35.8) 25 (42.4) .42
Clinical Dementia Rating Scale score, n (%) .39
0.5 10 (8.3) 1 (1.7)
1 33 (27.5) 20 (33.9)
2 60 (50.0) 31 (52.5)
3 17 (14.2) 7 (11.9)
Mini-Mental State Examination score,
meanSD
18.86.3 17.86.0 .17
Taking an AD medication, n (%)2 118 (98.3) 57 (96.6) .46
Taking a psychotropic medication, n (%)3 40 (33.3) 18 (30.5) .70
Number of psychotropic medications, n (%) .53
0 80 (66.7) 41 (69.5)
1 28 (23.3) 10 (16.9)
2–4 12 (10) 8 (13.6)
Functional Independence Measure total score,
meanSD
89.517.9 89.117.9 .95
Short Physical Performance Battery total score,
meanSD
9.72.2 9.92.0 .70
Neuropsychiatric Inventory score, meanSD
Total 12.811.3 16.615.2 .16
Hyperactivity 4.76.9 6.17.5 .13
Psychosis 1.52.6 2.85.2 .20
Mood 8.26.0 9.67.6 .28
Apathy 4.22.2 4.32.5 .97
Cornell Depression Scale score, meanSD 4.44.2 5.95.7 .14
Mini Nutritional Assessment score, n (%) .46
>23.5 (well nourished) 33 (27.5) 16 (27.1)
17–23.5 (at risk of malnutrition) 86 (71.7) 41 (69.5)
<17 (malnourished) 1 (0.8) 2 (3.4)
Number of regularly used medications,
meanSD
7.03.8 6.73.2 .89
Charlson Comorbidity Index, meanSD 2.41.6 2.71.6 .19
Fallen during prior year before the trial, n (%) 43 (36) 27 (46) .20
1Differences between the groups were tested using the t-test, bootstrapped type t-test, Wilcoxon rank-sum test, chi-square test, or Fisher–Freeman–Halton
test.
2Cholinesterase inhibitor (N06DA), memantine (N06DX01).
3Antipsychotic (N05A), antidepressant (N06A), anxiolytic (N05B), hypnotic and sedative (N05C).
SD=standard deviation.
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interaction effect was also significant (p = .009) (adjusted
for sex, age, MMSE score, SPPB score, and psychotropic
medication use).
DISCUSSION
These results show that a long-term exercise intervention
reduces the risk of falling related to NPS in individuals with
AD. The risk of falling increased linearly with NPI score in
the control group, but exercise eliminated this risk in the
intervention group. To our knowledge, no other study has
examined whether exercise modifies the risk of falling
related to NPS in community-dwelling people with AD.
This study has several strengths. Every participant had
a confirmed diagnosis of AD. The exercise interventions
were simple and clearly described.12 Adherence to the inter-
vention was high, and the outcome measures were valid.
Participants’ spouses recorded falls in daily fall diaries. This
method is highly sensitive to accurate recording of falls.24
The study also has some limitations that should be consid-
ered when interpreting the results. All participants were
community-dwelling Caucasians living with their spousal
caregivers. Because older couples were recruited, and men
are more likely to have a surviving spouse, two-thirds of
the participants with AD were men. Generalizing these
results to other groups of individuals AD should be done
with caution. Nevertheless, the baseline characteristics are
similar to those in previous studies of people with dementia,
supporting the reliability of the results in this group. This
was a secondary analysis of the original trial and thus was
not a randomized trial, although there were no significant
differences in baseline characteristics between the interven-
tion and control groups. Neuropsychiatric measures were
secondary endpoints of the study,13 so NPS scores were low
at baseline.
The results of this study are in line with those of the
few previous studies examining the relationship between
NPS and falls.8–10 Our study suggests that NPS are indepen-
dent risk factors for falls. The fall risk related to NPS could
be in part due to less day time physical activity because of
apathy, the most common NPS. Low activity may in turn
lead to frailty and risk of falls.25 This relationship should
be more carefully evaluated in future studies, for example
with activity monitors. The study intervention did not aim
to reduce psychotropic use, and therefore it seems likely
that the beneficial effects were related to exercise.
In accord with earlier studies, the number of NPS in
our study was low.26 Our study was originally designed to
improve physical functioning, but 175 participants scored
at least 1 point on the NPI, and 38 scored 20 points or
more. A clear linear relationship emerged between NPI
score and falls in the control group.
As shown in our previous study, no significant changes
in total NPI score or individual symptoms were detected in
the intervention or control group. This may be because of
the small number of NPS at baseline.13 Thus, the mecha-
nism behind the interaction of exercise, NPS, and falls was
due not to a decrease in NPS but probably to the beneficial
effects of exercise on muscles and balance. Even though
70% the study population was at risk of malnutrition, they
benefitted from the intervention. Another potential mecha-
nism is improvement in executive functioning because of
the exercise intervention reported in an earlier study exam-
ining the effects of exercise on cognition.27 NPS in AD are
common.28 They increase caregiver burden and predict
poor prognosis, including admission to institutional care.4
Although our intervention did not decrease the number of
symptoms, it had an effect on the consequences of NPS,
specifically falls.
CONCLUSIONS
This study revealed that NPS are linearly associated with
number of falls and that exercise has a significant modifying
effect on the risk of falling in community-dwelling people
with AD and NPS. The findings suggest that exercise has
the potential to reduce the risk of falls associated with NPS.
Further studies are needed to confirm these results.
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